Oxybutynin (Compound)

Synonyms:oxybutynin, 5633-20-5, Ditropan, Oxytrol, Oxibutyninum, kentera, Oxybutyninum, Oxybutinin, Oxybutynine, Oxibutinina, Oxybutynine [INN-French], Oxybutyninum [INN-Latin], Oxibutinina [INN-Spanish], 4-(diethylamino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate, 4-Diethylamino-2-butinyl alpha-cyclohexylmandelat, Ditropan Xl, Oxybutynin (Ditropan), 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate, 4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate, CHEMBL1231, CHEBI:7856, 4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester, K9P6MC7092, 5633-20-5 (free), Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester, Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester, Cystrin, Oxybutynin Base, Anturol, 4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate, transdermal patch, (R)-4-(Diethylamino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate, Lyrinel XL, Oxytrol for Women, Oxybutynin [USAN:INN:BAN], CCRIS 1923, Oxybutynin transdermal, oxybutynin topical gel, HSDB 3270, Oxybutynin transdermal patch, Oxybutinyn, UNII-K9P6MC7092, (RS)-oxybutynin, Anturol (TN), Oxytrol (TN), MFCD00865252, OXYBUTYNIN [MI], OXYBUTYNIN [INN], Oxybutynin (USAN/INN), Prestwick0_000287, Prestwick1_000287, Prestwick2_000287, Prestwick3_000287, OXYBUTYNIN [HSDB], OXYBUTYNIN [USAN], OXYBUTYNIN [VANDF], OXYBUTYNIN [MART.], SCHEMBL2992, OXYBUTYNIN [WHO-DD], Lopac0_000923, BSPBio_000194, GTPL359, MLS006010052, OXYBUTYNIN [EMA EPAR], SPBio_002413, BPBio1_000214, DTXSID0023406, OXYBUTYNIN [ORANGE BOOK], OXYBUTYNIN, Oxybutynin chloride, CHEBI:144551, HMS3884K08, BCP12179, HY-B0267, AB7701, BDBM50165019, s1754, AKOS015896242, Cyclohexaneglycolic acid, .alpha.-phenyl-, 4-(diethylamino)-2-butynyl ester, AC-2153, CCG-205005, DB01062, KS-5221, SDCCGSBI-0050898.P003, MRF-0000601, (+/-)-OXYBUTYNIN(Hydrochloride form), NCGC00015767-03, NCGC00015767-04, NCGC00015767-06, NCGC00015767-07, NCGC00015767-09, NCGC00015767-10, NCGC00015767-21, NCGC00089795-02, SMR001550466, SBI-0050898.P002, FT-0603679, SW196787-3, C07360, D00465, EN300-6478839, A831004, L000923, Q1060922, BRD-A65013509-003-03-8, BRD-A65013509-003-13-7, Z2588038990, 4-(Diethylamino)-2-butynyl .alpha.-phenylcyclohexaneglycolate, 4-(Diethylamino)-2-butynyl cyclohexyl(hydroxy)phenylacetate #, 4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)(phenyl)acetate, 4-diethylaminobut-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate, rac-4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate, (R)-4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate, (2R)-2-cyclohexyl-2-hydroxy-2-phenylacetic acid 4-(diethylamino)but-2-ynyl ester, alpha-cyclohexyl-alpha-hydroxybenzeneacetic acid 4-(diethylamino)-2-butynyl ester, Benzeneacetic acid, a-cyclohexyl-a-hydroxy-,4-(diethylamino)-2-butynyl ester, Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butyn-1-yl ester, 119579-36-1
Pubchem:PUBCHEM:4634
Id:0b453f86-3e41-5cac-98d3-6bc585f71567
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Oxybutynin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Oxybutynin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Oxybutynin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.